baber/WOPTO huggingface dataset:
Patent DE-10205656-C9 (DE)
Title: Textilmaschine mit zumindest einer Wartungseinrichtung
Inventor: ZIPPERER MARTIN
IPC: D01H4/48
Filed: 2002-02-12
Granted: 2019-12-24
Abstract: Textilmaschine mit zumindest einer ersten Wartungseinrichtung, die längs einer Führungsschiene (15, 16) entlang einer Vielzahl von Bearbeitungsstellen (13) der Textilmaschine (10) zum Warten und/oder Kontrollieren der Bearbeitungsstellen (13) verfahrbar ist, und einer Steuereinrichtung zur Steuerung der Fahrbewegung der Wartungseinrichtung (14a-d), dadurch gekennzeichnet, daß in der Steuereinrichtung (20a, 20b; 22) Daten von bekannten Hindernissen (14a-d) hinterlegbar sind, wobei die Daten die Art des Hindernisses beinhalten,und die Steuereinrichtung (20a, 20b; 22) die Fahrbewegung in Abhängigkeit der Daten der Hindernisse (14a-d) steuert, wobei hindernisabhängige Maßnahmen berücksichtigt werden.
Patent DK-22384-D0 (DK)
Inventor: ALLAN PAUL
IPC: H04M3/56
Filed: 1984-01-18
Abstract: A conference bridge for a digital time division multiplex pulse code modulation telecommunication exchange in which for simplicity of operation each conference is allocated a unique channel number and each party within a conference is allocated a unique party number thus allowing any party to join any conference at any time.
Patent DK-84785-D0 (DK)
Inventor: ROSSIGNOL JEAN FRANCOIS
IPC: C07D401/06
Filed: 1985-02-25
Abstract: Compounds of formula (I): 
<CHEM>
 wherein n is 1 or 2, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of malaria are disclosed.
Patent DK-148183-D0 (DK)
Inventor: HILBOLL GERD
IPC: A61K31/41
Filed: 1983-03-30
Abstract: The present invention relates to new 6-[Imidazolyl-phenyl]-5-methyl-3-oxo-tetrahydropyridazines of the general formula I    <IMAGE>  I  as well as their acid addition salts, methods for their use, and pharmaceutical preparations containing them.
Patent DK-267285-D0 (DK)
Inventor: SAARI OLIVER
IPC: F16H25/24
Filed: 1985-06-13
Abstract: A lead screw and nut assembly (10) for converting a rotary input into a linear output, includes an involute-heliocoidal lead screw (12), and a nut assembly (14). The nut assembly (14) includes an annular ring (50) and a number of grooved rollers (40) congugate to the thread on the lead screw (12). The annular ring (50) is mounted in bearing means (60) located in an outer housing (30, 32) of the nut assembly (14) so that it can rotate freely. Rolling line contact is established between the lead screw (12), the rollers (40) the ring (50) and the outer housing (30,32) for the transmission of major forces in the axial direction of the lead screw.
Patent DK-285289-D0 (DK)
Inventor: ANDERSEN JAN RUD
IPC: G01N21/27
Filed: 1989-06-12
Abstract: The invention relates to a method and an apparatus for the photometric determination of properties of meat pieces, particularly the concentration of substances comprised therein, such as the pigment and protein content of meat, which are based on measuring the intensity of light, reflected from a meat surface whithin a predetermined wavelength range, and determining a quantitative value of the respective meat property therefrom. According to the invention, the measurements are made at a plurality of different wavelenghts, e.g. 32, covering a continuous wavelength range or spectrum. The obtained values are inserted as variables into a multi-variable equation or algorithm, the concentration values are calculated therewith. The method and apparatus of the invention may be applied to pieces of meat which are conveyed on a slaughter line. The property determination is quick and so accurate that the pieces of meat may be graded immediately in accordance with the determined property.
Patent DK-547983-D0 (DK)
Inventor: WIELEN FRED MATTHIAS VAN DER
IPC: E06B3/26
Filed: 1983-11-30
Abstract: 1. Method for the production of thermally-insulated composite sections for window frames or the like, which have at least two metal section parts (1, 2), which are connected with each other through at least one intermediate piece (15) of thermally insulating material, in which the two metal section parts are firstly integrally connected with each other by at least one connecting cross-piece (3) of the same material, and at least one channel (11), preferably open to the exterior, being formed and being filled with the thermally insulating material forming the intermediate piece, and in which, after hardening of the insulating material, the connecting cross-piece is separated at predetermined, weakened separation points (20) and removed, characterised in that the connecting cross-piece is continuously subjected to a tensile load, acting in the plane of the connecting cross-piece and transversely to its longitudinal extent, in the transition zone (20) between the connecting cross-piece and the metal section parts connected therewith in the longitudinal direction, and is thereby continuously separated from the metal section parts.
Patent NO-890609-D0 (NO)
Inventor: LANGE LOTHAR
IPC: A61B8/00
Filed: 1989-02-13
Abstract: Contrast agents for ultrasonic diagnosis consisting of gas bubbles and microparticles are described and are characterised in that they contain as microparticles a mixture of at least one (C10-C20)-fatty acid with at least one solid which has no interfacial activity, suspended in a liquid vehicle. They provide contrast in ultrasonic imaging of the right and left heart, the myocardium and other organs such as the liver, spleen and kidney, after intravenous administration.
Patent NO-891260-D0 (NO)
Inventor: CIGANEK ENGELBERT
IPC: C07D405/04
Filed: 1989-03-22
Abstract: Known and novel 4-aryl-4-piperidinecarbinols and heterocyclic analogs are useful as analgesics. Also provided are novel pyrrolidinecarbinols and hexahydroazepin carbinols which are useful as analgesics, antidepressants and, in some cases, as anorectic agents.
Patent NO-892806-D0 (NO)
Inventor: SCHULTE-LIPPERN GUENTER
IPC: H02B1/48
Filed: 1989-07-06
Abstract: The object of the invention is to design the spreading claws of installation apparatuses fixed in flush-type wall-mounting sockets in such a way that a stable and durable spreader resetting is ensured with simple means, cost-effective manufacturing outlay and easily realised assembly with a loosened adjusting screw. According to the invention it is proposed that the free end of a second leaf spring leg (6) of a resilient leaf spring (2) is fastened to the second spreading claw leg (4), the second leaf spring leg (6) and the second spreading claw leg (4) being parallel, and the second leaf spring leg (6) being angled by a leaf spring knee angle  beta < alpha with respect to a first leaf spring leg (5) of the leaf spring (2) and that there is formed at the free end of the first leaf spring leg (5) a sliding bent piece (7) which lies on parts of the support ring (12) and is supported there with pretensioning. The design of the spreading claws according to the invention substantially facilitates the assembly and disassembly of flush-type installation apparatuses. <IMAGE>
Patent NO-902931-D0 (NO)
Inventor: KITTLE CARL EDWIN
IPC: B60W10/02
Filed: 1990-07-02
Abstract: A clutch control system for the front wheel drive clutch of a four-wheel drive vehicle engages the front wheel drive clutch as a function of three brake-operated switches, a pair of manually-operated "OFF-ON-AUTO" mode switches and a pair of speed responsive switches connected between a battery and the solenoid of a front wheel drive clutch control valve. The system engages the clutch when vehicle speed is above a limit speed and both service brakes are applied even when the mode switches are in their "OFF" position wherein the clutch is normally disengaged.
Patent NO-904809-D0 (NO)
Inventor: ANDERSSON JAN ANDERS ROLAND
IPC: A61M15/00
Filed: 1990-11-05
Abstract: The present invention refers to a device in connection with an inhaler intended for measuring and recording the course of inhalation of a patient. The device is intended for use in medication, e.g. in clinical tests, where there is a need of afterwards being able to control if the patient has taken medicine in a prescribed way. The device comprises an electronical unit provided in the inhaler for recording of the time for each dosage of the medicine of the inhaler. A detector (16, 32, 36) is provided in the inhaler in connection with a passage for the airflow of the inhalation, whereby the detector detects the airflow of the inhalation through the inhaler as well as the availability of the medicine at the inhalation, so that a combination of these two detected values decides if and how the performed inhalation should be recorded in the electronical unit (11, 33, 35).
Patent NO-922635-D0 (NO)
Inventor: TURCONI MARCO
IPC: A61P25/28
Filed: 1992-07-03
Abstract: New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives and physiologically acceptable acid addition salts and solvates thereof in the treatment of organic mental diseases, as for example dementia and amnestic syndromes. Pharmaceutical compositions containing them are also described.
Patent NO-930490-D0 (NO)
Inventor: VOSTERS PHILIPPE
IPC: C08L23/06
Filed: 1993-02-11
Abstract: A floor- and/or wall-covering formulation comprising:   (a) 100 parts by weight of an optionally functionalized, linear or star-shaped diene block copolymer containing at least one block derived from predominantly conjugated diene having a number average molecular weight in the range of from 20,000 to 100,000, which optionally has been hydrogenated whereby at least 80% of the aliphatic double bonds has been hydrogenated; (b) 100-400 parts by weight of polyethylene or a copolymer of ethylene and propylene having a melt index in the range of from 0.1 to 30 dg/min;   (c) 300-900 parts by weight of a functionalized polyalkylene; (d) 5-150 parts by weight of polyisobutylene having an average viscosity molecular weight in the range of from 40,000 to 5,000,000;   (e) 100-1500 parts by weight of a filler; and (f) 0-50 parts by weight of additives, such as antioxidants, flame retarders, antistatica, colouring agents and stabilizers. p
Patent NO-930819-D0 (NO)
Inventor: ACKERMANN JEAN
IPC: C07D413/12
Filed: 1993-03-05
Abstract: The novel sulphonamidocarboxamides of the formula <IMAGE>  in which     X is a group of the formula X<1> or X<2>: <IMAGE>   T is CH2 or O, and A, M, Q and Y have the meaning given in the description, and hydrates or solvates thereof inhibit the platelet aggregation and clotting of fibrinogen in the plasma induced by thrombin. They are prepared by amidination of a cyclic amino group representing the group X or by C(O)Q amide formation.
Patent NO-931571-D0 (NO)
Inventor: PARK JOHN Y
IPC: G01N33/82
Filed: 1993-04-29
Abstract: A composition and method useful to quickly and effectively indicate whether a functional component such as catalase has been added to a clear solution such as a hydrogen peroxide solution involves compounding with the functional component an effective amount of vitamin B-12 such that when the compounded composition is added to the clear solution, the clear solution turns rose colored. By observing the rose color, the user can determine that the functional component has been added to the clear solution.
Patent NO-933521-D0 (NO)
Inventor: WEIDMANN KLAUS
IPC: A61K31/4418
Filed: 1993-10-01
Abstract: The invention relates to acylsulphonamido- and sulphonamidopyridine-2-carboxylic acid esters and their pyridine-N-oxides of the general formula I <IMAGE>  in which     A = R<3> and B = X-NR<5>R<6> or   B = R<3> and A = X-NR<5>R<6>.   The compounds are suitable as medicaments against fibrotic diseases.
Patent NO-940774-D0 (NO)
Inventor: METCALF BENJAMIN J
IPC: C12R1/16
Filed: 1994-03-04
Abstract: The invention pertains to a novel method and plasmid system for producing abundant quantities of CRM197 protein, diphtheria toxin or other CRM proteins related to diphtheria toxin, as well as to microorganisms transformed with the novel plasmid. A particularly preferred DNA plasmid, designated pPX 3511, that combines the gene for CRM197 from the nontoxigenic betaphage and the plasmid pNG2-22 is described. The novel plasmid system is capable of transforming strains of Corynebacterium diphtheriae into strains which are capable of expressing high levels of the CRM197 protein without the use of multiple lysogens. The invention provides in elegant means for increasing protein production without having to manipulate the expression vector, such as by increasing the promoter strength, or removing the promoter from iron regulation.
Patent NO-943874-D0 (NO)
Inventor: CHANDRASEKHAR SRINIVASAN
IPC: A61K31/445
Filed: 1994-10-13
Abstract: A method of treating resistant neoplasms comprising administering to a human or other mammal in need of treatment an effective amount of a compound having the formula <CHEM>     wherein R<1> and R<3> are independently hydrogen, -CH3, <CHEM>  or <CHEM>  wherein Ar is optionally substituted phenyl; R<2> is selected from the group consisting of pyrrolidino, hexamethyleneimino, and piperidino, a pharmaceutically acceptable salt or solvate thereof.
Patent NO-944564-D0 (NO)
Inventor: KLEINSCHROTH JURGEN
IPC: A61K31/407
Filed: 1994-11-29
Abstract: The present invention is concerned with the use of indolocarbazole imides of the general formula (I): for the preparation of pharmaceutical compositions for the treatment and/or prevention of cancer, virus diseases (for example HIV infections), heart and blood vessel diseases (for example high blood pressure, thromboses, heart rhythm disturbances and atheroscleroses), bronchopulmonary diseases, degenerative diseases of the central nervous system (for example Alzheimer's disease), inflammatoryl diseases (for example rheumatism and arthritis), diseases of the immune system (for example allergies), as well as psoriasis and for use as immune suppressives; as well as new compounds of general formula (I).
Patent NO-945018-D0 (NO)
Inventor: ATKINS DAVID G
IPC: C12N7/00
Filed: 1994-12-23
Abstract: The invention consists of a non-naturally occurring nucleic acid molecule capable of blocking or interfering with a replicative intermediate of a virus, a virusoid, or a viroid. The nucleic acid molecule may contain a ribozyme or a plurality of ribozymes. Alternatively, the nucleic acid molecule may be an antisense nucleic acid molecule. The ribozyme may be a hairpin ribozyme, a hammerhead ribozyme, an RNAase P ribozyme, a minizyme, or other catalytic RNA molecule. The virus may be an animal, a mammalian, a plant, a fungal, a protozoan, a yeast, a bacterial virus, or a human virus. The nucleic acid molecule may be expressed in the cell or it may be preformed and administered (ex vivo). The present invention contemplates methods of controlling infection of a pathogenic infectious agent in a plant or animal.
Patent NO-970513-D0 (NO)
Inventor: ROSENBERG STEVE
IPC: C07K5/06
Filed: 1997-02-05
Abstract: Compounds of the invention inhibit urokinase plasminogen activator:   <IMAGE>   where R1 is lower alkyl, lower alkenyl, lower alkynyl, aryl, aralkyl, aryl-alkenyl, aryl-alkynyl, aryl-cycloalkyl, unsubstituted or substituted with 1-3 halo, OH, NH2, lower alkyl, halo-lower alkyl, lower alkoxy, lower alkylamino, lower alkylthio, CN or NO2; R2 is aryl or aralkyl, unsubstituted or substituted with 1-3 halo, OH, NH2, CN, NO2, lower alkyl, halo-lower alkyl, lower alkoxy, lower alkylamino, lower alkylthio, or cycloalkyl; R3, R5 and R9 are each independently H or lower alkyl; R4 is   <IMAGE>    where R6 and R7 are each independently H, OH, NH2, CN, NO2, lower alkyl, halo-lower alkyl, lower alkoxy, lower alkylamino, lower alkylthio, or cycloalkyl, and n and m are each independently an integer from 1 to 3 inclusive; and pharmaceutically acceptable acid addition salts thereof.
Patent NO-975247-D0 (NO)
Inventor: LEE DOSUK D
IPC: A61F2/02
Filed: 1997-11-14
Abstract: The present invention provides a process for converting a standard inert amorphous calcium phosphate precipitate into highly reactive amorphous solids. The amorphous solids can be used to react with other calcium phosphate solids to form a poorly-crystalline synthetic hydroxyapatite that provides both bioactivity and structural integrity. This novel amorphous material can be reacted with other calcium phosphates at or below 37 °C to form a bone-like material consisting of poorly cyrstalline hydroxyapatite.
Patent NO-983099-D0 (NO)
Inventor: VAZQUEZ MICHAEL L
IPC: A61K31/505
Filed: 1998-07-03
Abstract: The present invention provides retroviral protease inhibitor compounds represented by the Formula I: <CHEM>   Such compounds are urseful for preparing medicaments for inhibiting proteases, especially for inhibiting HIV protease and for treating a retroviral infection such as HIV infection and for treating AIDS.
Patent NO-983945-D0 (NO)
Inventor: DIMAIO JOHN
IPC: A61K31/00
Filed: 1998-08-27
Abstract: PCT No. PCT/SE97/00315 Sec. 371 Date Oct. 6, 1997 Sec. 102(e) Date Oct. 6, 1997 PCT Filed Feb. 25, 1997 PCT Pub. No. WO97/31940 PCT Pub. Date Sep. 4, 1997The present invention is directed to compounds that act as analgesics and that have the structure of formula (I): wherein; Z is wherein, n is 1 or 2, and R0 is C6-12 aryl or C7-8 aralkyl; or R1 is selected from the group consisting of hydrogen; -NH-C1-6 alkyl; C1-6 alkyl; C6-12 aryl; C7-18 aralkyl; arginyl; and R30NHC(=NH)-, wherein R30 is hydrogen, C6-12 aryl, C7-18 aralkyl, or C1-6 alkyl; R2 is hydrogen; C1-6 alkyl; or OH; R3 is C6-12 aryl; C7-18 aralkyl; -CH2-C6H2R8R9;or -CH2-OHC6HR8R9, wherein each of R8 and R9 is independently, or hydrogen; R4 C6-12 aryl; C7-18 aralkyl; C1-12 alkyl; or a substituted or unsubstituted cyclohexyl; R5 is C1-6 alkyl; hydrogen; OH; halogen; SH; NO2; NH2; -NH-C1-6 alkyl; NH2C (=NH-; NH2C (=NH)-NH-; COOR31, wherein, R31 is hydrogen, or C1-6 alkyl; X is CH2NHC(O)-; CH2NHC(O)O; -C(O)NH-; or CH2NH-; and L is a C1-12 alkylene chain which can be substituted with at least one substituent selected from the group consisting of; a C3-C12 cycloalkyl containing at least one heteroatom; C1-6 alkyl; OR31; -NHC(O)R33; -OC(O)R34 -NHR35 wherein; and NR6R7; with the proviso that when R5 is hydrogen, Z is and X is -C(O)NH-, or -CH2NH-, then L is a C1-12 alkyl chain substituted with at least one substituent selected from the group consisting of; a C3-C12 cycloalkyl containing at least one heteroatom; C1-6 alkyl; OR31; SR32; -NHC(O)R33; -OC(O)R34, -NHR35; and NR6R7.
Patent NO-992246-D0 (NO)
Inventor: MORGENSTERN DAVID A
IPC: C07F9/38
Filed: 1999-05-07
Abstract: The present invention relates to an oxidation catalyst comprising a noble metal and an electroactive molecular species absorbed thereon. The catalyst is particularly suitable in a process for converting N-substituted N-(phosphonomethyl) glycines, salts and esters thereof, to N-(phosphonomethyl) glycine, salts and esters thereof.
Patent NO-993844-D0 (NO)
Inventor: VOEGELE HARALD
IPC: A61M16/00
Filed: 1999-08-10
Abstract: A method of changing to the inhalation or exhalation phase in the CPAP therapy is provided. By means of a first, high threshold value and a second, low threshold value, nonspecific influences on the first derivative of the gas flow curve are suppressed in the respective breathing phase and the transition to the respective next gas phase is determined with high sensitivity. The advantages of the invention are in a higher precision of the changing operation and in a greater safety for the patient.
Patent GB-0004958-D0 (GB)
Title: Capillary reactor distribution device and method
IPC: B01L3/00
Filed: 2000-03-02
Abstract: A capillary reactor distribution device comprising first and second capillary pathways ( 2, 3 ) which meet at a junction ( 5 ) and a third capillary pathway ( 4 ) which leads away from the junction ( 5 ), the capillary pathways ( 2, 3, 4 ) being dimensioned such that, when first and second immiscible fluids ( 14, 15 ) are fed along respectively the first and second capillary pathways ( 2, 3 ) under predetermined laminar flow conditions, the first and second fluids ( 14, 15 ) chop each other into discrete slugs ( 16, 17 ) which pass along the third capillary pathway ( 4 ). Molecular mixing between the fluids ( 14, 15 ) takes place by way of axial diffusion between adjacent slugs ( 16, 17 ) and by way of internal circulation within each slug ( 16, 17 ) as the slugs ( 16, 17 ) progress along the third capillary pathway ( 4 ).
Patent GB-0010683-D0 (GB)
Title: Cancer therapy
IPC: A61K47/48
Filed: 2000-05-03
Abstract: Use of a steroid hormone or steroid hormone analogue and at least a portion of HPV E2 protein in the preparation of a pharmaceutical composition for the treatment of cervical cancer.
Patent GB-0011169-D0 (GB)
Title: Improvements in or relating to medicinal compositions
IPC: A61K41/00
Filed: 2000-05-10
Abstract: Ispaghula (material from the plant Plantago ovata, useful as an agent in relieving constipation, is subjected to treatment with -radiation at a dose of up to 13 kGy, and preferably in the range 5-10 kGy. As well as effecting sterilisation of the ispaghula, this dose of irradiation has been shown to offer surprising rheological advantages.
Patent GB-0025917-D0 (GB)
Title: Access permissions for group calls
IPC: H04W84/18
Filed: 2000-10-23
Abstract: A method for setting up a group call within a dispatch radio communication system is disclosed. Additional stations which are not programmed to respond to a transmitted group identification code (GIC) are enabled to join the call. The method comprises steps carried out by a service provider of (a) providing first and second additional fields in a set-up message, the first additional field carrying a Group Call Access Permission (GCAP) value and the second additional field carrying a Help Request Level (HRL) value, (b) enabling a call initiator to select a GCAP value, according to a range of stations the call initiator wishes to reach, and a HRL value, according to an assigned call priority, for transmission alongside the GIC in the step (a) fields, and (c) enabling any station that receives a set-up message to determine whether to join the call based on the GCAP and HRL values.
Patent GB-0031137-D0 (GB)
Title: Flavour concentrates
IPC: A23L27/30
Filed: 2000-12-20
Abstract: A process for the production of flavour concentrates comprising the addition of a mixture of flavour precursors comprising (A) proline, ornithine or protein hydrolysate, and (B) rhamnose, fructose or fucose, to a fat-based medium and heating the mixture to about 100-140 DEG C for about 10-120 minutes.
Patent GB-0111549-D0 (GB)
Title: Polymers, their preparation and uses
IPC: C09K11/06
Filed: 2001-05-11
Abstract: 1) A polymer for use in an optical device comprising:  a hole transporting region an electron transporting region an emissive region   said polymer comprising an optionally substituted repeat unit of formula (I): <CHEM> wherein each Ar is the same or different and comprises an optionally substituted aryl group.
Patent GB-0124742-D0 (GB)
Title: Biodegradable materials
IPC: C08L71/02
Filed: 2001-10-16
Abstract: A biodegradable material for use in making items usable in surgery and related fields of medicine. The material comprising a bioabsorbable thermoplastic polymer component and a bioactive filler material. In components made of the material particles of the filler material occur embedded within the surface of the components.
Patent GB-0125890-D0 (GB)
Title: Exhaust system for an internal combustion engine
IPC: F01N13/02
Filed: 2001-10-27
Abstract: An exhaust system for an internal combustion engine comprises a catalysed particulate filter comprising a NOx absorbent capable of absorbing NOx contained in an exhaust gas when the composition of the exhaust gas is lambda >1, and capable of releasing the NOx absorbed in the NOx component when the exhaust gas composition is 1>=lambda, characterised in that the exhaust system further comprises a catalyst capable of oxidising NO to NO2 at least when the air-fuel ration of the exhaust gas is lean.